MedAlliance Launches PRISTINE Study Of SELUTION SLR Drug-Eluting Peripheral Balloon

SELUTION SLR is the first drug-eluting balloon accepted by the FDA as part of its breakthrough program, according to the company.

PAD. Peripheral Artery Disease acronym on sticky notes. Office desk background
• Source: shutterstock.com

More from Clinical Trials

More from R&D